PATENT CLAIM ANALYSIS

Application Number: 16152008
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["544", "366000"]

Abstract:
Provided herein are Itraconazole analogs. Also provided herein are methods of inhibition of Hedgehog pathway, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, angiogenesis and treatment of disease with Itraconazole analogs.

Claim (Index 5):
A method of treating cancer comprising administering an effective amount of a compound having a structure of Formula (IX).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.27586
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14343040', '15225021', '15481542', '14156314', '14753537']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7565991023817187
- 35 USC 102 Novelty (BERT): 0.5387187920259243
- Combined Prediction Score: 0.7348110713461392
- Mean Citation Score: 330.6821940000001
- Max Citation Score: 383.66406
- Similarity Product: 219.41825730988023

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test